ExcitePCR is developing the FireflyDXTM family of pathogen detection systems, portable devices offering rapid sample-to-result detection in less than 30 minutes using real-time polymerase chain reaction (PCR) chemistry. FireflyDX devices will be capable of multiplex assays and utilize single-use, disposable cartridges for lab-quality results at the Point-of-Need and Point-of-Care (PON / POC). The FireflyDX systems combine sample lysis, purification, realtime PCR analysis, and reporting of results. The initial, primary use of these systems are expected to be in clinical and molecular diagnostic settings, agricultural screening in domestic sectors and developing countries, PON / POC monitoring of pathogenic outbreaks, and for ...
ExcitePCR is developing the FireflyDXTM family of pathogen detection systems, portable devices offering rapid sample-to-result detection in less than 30 minutes using real-time polymerase chain reaction (PCR) chemistry. FireflyDX devices will be capable of multiplex assays and utilize single-use, disposable cartridges for lab-quality results at the Point-of-Need and Point-of-Care (PON / POC). The FireflyDX systems combine sample lysis, purification, realtime PCR analysis, and reporting of results. The initial, primary use of these systems are expected to be in clinical and molecular diagnostic settings, agricultural screening in domestic sectors and developing countries, PON / POC monitoring of pathogenic outbreaks, and for the detection of biological agents associated with weapons of mass destruction.
-
Number of Employees:
25-100
-
Annual Revenue:
$1-10 Million